Navigation Links
Marwan Khaled Tayeh, Ph.D., is awarded the 2010 Richard King Trainee Award
Date:4/5/2010

Marwan Khaled Tayeh, Ph.D. is the recipient of the second annual Richard King Trainee Award. This award was instituted by the American College of Medical Genetics Foundation (ACMGF) to encourage ABMG trainees in their careers and to foster the publication of quality research in Genetics in Medicine.

Each year the editorial board will review all articles published in GIM by an ABMG trainee who was either a first or corresponding author during that year. The manuscript felt to have the most merit will be selected and a cash prize awarded at the annual American College of Medical Genetics (ACMG) meeting.

Dr. Tayeh is the 2010 recipient of the award for his manuscript "Targeted comparative genomic hybridization (CGH) array for the detection of single-and multi-exongene deletions and duplications" published in April's Genetics in Medicine.

The award is given by the American College of Medical Genetics Foundation and is named for Dr. Richard King in recognition of his instrumental role in creating Genetics in Medicine and serving as the first Editor-in-Chief of the journal.

"GIM is pleased to have published this work by Dr. Tayeh. The award is well deserved, demonstrating the feasibility of using CGH array analysis in the identification of deletions and duplications which can be responsible for a variety of human diseases," said James P. Evans MD, PhD, FACMG, Editor-in-Chief; Genetics in Medicine. "This is an example of the kind of robust genomic analysis with has propelled mutation detection in clinical medicine. Genetics in Medicine is proud to have published this work by a promising trainee in the field of Medical Genetics."

Eligible trainees include those in the following programs:

Clinical Biochemical Genetics
Clinical Cytogenetics
Clinical Molecular Genetics
Combined Internal Medicine/Genetics
Combined Pediatrics/Genetics
PhD Medical Genetics


'/>"/>
Contact: Kathy Beal
kbeal@acmg.net
301-238-4582
American College of Medical Genetics
Source:Eurekalert

Page: 1 2

Related biology news :

1. AACR applauds nomination of Francis S. Collins, M.D., Ph.D., to be the new NIH director
2. Sihoun Hahn, M.D., Ph.D., FACMG is the 2009-2010 Luminex/ACMGF Award recipient
3. BIDMC scientist John Rinn, Ph.D., receives Damon-Runyon Rachleff Innovation Award
4. Leading conservation scientists awarded prestigious 2010 Tyler Environmental Prize
5. Ayman El-Hattab, MD is awarded the 2010 Genzyme/ACMG Foundation Genetics Fellowship
6. 5th Annual Szent-Györgyi Prize for Progress in Cancer Research awarded
7. Keystone Symposia awarded $1.37 million, 5-year NIH grant to fund ongoing diversity efforts
8. Vilcek prizes in biomedical science awarded
9. Charles Drew University, UC Irvine awarded $480,000 grant for research low birth weight infants
10. NJIT researcher awarded patent for hydrophobic, corrosion-resistant coating
11. MSU researcher awarded $2 million to tackle parasitic tropical diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2015)... Calif. , July 9, 2015  Unchained ... today announcing its acquisition of Avid Nano. Avid ... light scattering (DLS) systems.    Also ... smallest, fastest and easiest to use protein sizing ... that measures a protein,s hydrodynamic size, size distribution, ...
(Date:7/8/2015)... , July 8, 2015 Summary Pancreatic ... the fourth most fatal, with a mortality rate of ... prognosis of pancreatic cancer patients has highlighted a significant ... is not being met by the current market. ... of products with varying molecule types and mechanisms of ...
(Date:7/8/2015)... DIEGO , July 8, 2015  Trovagene, ... cell-free molecular diagnostics, today announced the launch of ... the Company,s Precision Cancer Monitoring℠ (PCM) technology for ... receiving one or a combination of the novel ... Opdivo® (nivolumab), a PD-1 inhibitor. The 50-patient study ...
Breaking Biology News(10 mins):Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
... 7, 2008 The Global Innovation Imperatives (Gii) ... for their first session at the American Chemical ... Gii, a joint collaboration between the ACS Committee ... Industry, seeks to combat worldwide health, environmental and ...
... is a poorly understood condition that incapacitates and affects the ... In the US, it affects approximately six million women and ... It is a chronic painful disease which occurs when ... the area of the ovaries and fallopian tubes, but can ...
... the fact that millions of Americans are believed to have ... to treat many of these people. That is due in ... are varied and complex, ranging from chronic allergies, viral infection, ... percent of Americans have lost their sense of smell and ...
Cached Biology News:At ACS' national meeting, global initiative set to tackle water issues 2New study finds uncontrollable stress worsens symptoms of endometriosis 2New study finds uncontrollable stress worsens symptoms of endometriosis 3For some who have lost their sense of smell, a once popular asthma drug could help 2For some who have lost their sense of smell, a once popular asthma drug could help 3
(Date:7/30/2015)... 2015   GenoSpace , a leading provider ... analysis of genomic and other biomedical data, today ... the company as Vice President of Sales and ... "GenoSpace partners with its customers ... and explore complex sets of genomic, phenotypic and ...
(Date:7/30/2015)... CA (PRWEB) , ... July 30, 2015 , ... ... successful completion of a field clinical study of its canine osteoarthritis stem cell ... with Aratana Therapeutics (Kansas City, KS) and will be marketed in the US ...
(Date:7/30/2015)... 30, 2015 Ascendis Pharma A/S (Nasdaq: ... its innovative TransCon technology to address significant unmet ... a six-month Phase 2 study to evaluate the ... in 53 treatment-naïve, pre-pubertal children with growth hormone ... pleased with the top-line results from our Phase ...
(Date:7/30/2015)... ... July 30, 2015 , ... GEA's ... designed for continuous operation up to 1500 bar. The sanitary design gauge of ... preventing toxic contamination. , The Pony™ NS2006L homogenizer is an ideal solution for ...
Breaking Biology Technology:GenoSpace Introduces Matthew Fischer as Vice President of Sales and Marketing 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2
... ... Countries, - Competitors Precluded from Immediate Commercialization of Competitive ... Products, ... TSX.V.NTB) announces that the,European Patent Office (EPO) granted on May 31st 2007 Neptune,s composition,of ...
... Expected to Yield Multiple New Drug Products for Aida,s ... ... Calif., March 27 Aida,Pharmaceuticals, Inc (OTC Bulletin Board: AIDA) today ... Jiangsu,Institute of Microbiology Co., Ltd. ("JSIM") Aida,s subsidiary, Hanzhou,Aida Pharmaceuticals Co., ...
... through conversion of agricultural ... products into advanced materials, COLUMBUS, Ohio, ... representing a wide range of expertise in the,fields of chemicals, ... Chemicals, Polymers, and Advanced Materials Task Force. The,creation of the ...
Cached Biology Technology:Neptune Technologies patent granted for novel phospholipids in multiple diseases and pharmaceutical applications 2Neptune Technologies patent granted for novel phospholipids in multiple diseases and pharmaceutical applications 3Aida Acquires High-Level Research Institute in China 2Ohio Task Force Begins Mission of Creating a New 21st Century Industry 2Ohio Task Force Begins Mission of Creating a New 21st Century Industry 3
Plasmid expressing the LacZ reporter gene....
... flasks have triple baffles located at the ... maximal oxygen transfer to culture medium. These ... wide range of optional caps are available ... caps for ease of sorting and identification ...
...
... mouth PYREX Fernbach-style culture flask is designed for ... volume ratio. It can also be used in ... edges to achieve maximal oxygen transfer to culture ... and accepts cotton plugs or No. 13 rubber ...
Biology Products: